Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 16:9:844826.
doi: 10.3389/fmolb.2022.844826. eCollection 2022.

Role of ATP-Small Heat Shock Protein Interaction in Human Diseases

Affiliations
Review

Role of ATP-Small Heat Shock Protein Interaction in Human Diseases

Sandip K Nandi et al. Front Mol Biosci. .

Abstract

Adenosine triphosphate (ATP) is an important fuel of life for humans and Mycobacterium species. Its potential role in modulating cellular functions and implications in systemic, pulmonary, and ocular diseases is well studied. Plasma ATP has been used as a diagnostic and prognostic biomarker owing to its close association with disease's progression. Several stresses induce altered ATP generation, causing disorders and illnesses. Small heat shock proteins (sHSPs) are dynamic oligomers that are dominantly β-sheet in nature. Some important functions that they exhibit include preventing protein aggregation, enabling protein refolding, conferring thermotolerance to cells, and exhibiting anti-apoptotic functions. Expression and functions of sHSPs in humans are closely associated with several diseases like cataracts, cardiovascular diseases, renal diseases, cancer, etc. Additionally, there are some mycobacterial sHSPs like Mycobacterium leprae HSP18 and Mycobacterium tuberculosis HSP16.3, whose molecular chaperone functions are implicated in the growth and survival of pathogens in host species. As both ATP and sHSPs, remain closely associated with several human diseases and survival of bacterial pathogens in the host, therefore substantial research has been conducted to elucidate ATP-sHSP interaction. In this mini review, the impact of ATP on the structure and function of human and mycobacterial sHSPs is discussed. Additionally, how such interactions can influence the onset of several human diseases is also discussed.

Keywords: ATP; cardiovascular diseases; cataract; leprosy; sHSPs; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Effect of phosphorylated HSP20 on cardiac injury vs non-phosphorylated one.
FIGURE 2
FIGURE 2
Influence of ATP in human diseases mediated by small heat shock proteins.

References

    1. Ansari-Ramandi M. M., Maleki M., Alizadehasl A., Amin A., Taghavi S., Alemzadeh-Ansari M. J., et al. (2017). Safety and Effect of High Dose Allopurinol in Patients with Severe Left Ventricular Systolic Dysfunction. J. Cardiovasc. Thorac. Res. 9, 102–107. 10.15171/jcvtr.2017.17 - DOI - PMC - PubMed
    1. Arrigo A. P., Simon S., Gibert B., Kretz-Remy C., Nivon M., Czekalla A., et al. (2007). Hsp27 (HspB1) and alphaB-Crystallin (HspB5) as Therapeutic Targets. FEBS Lett. 581, 5813665–5813674. 10.1016/j.febslet.2007.04.033 - DOI - PubMed
    1. Basha E., O’Neill H., Vierling E. (2012). Small Heat Shock Proteins and α-crystallins: Dynamic Proteins with Flexible Functions. Trends Biochem. Sci. 37, 106–117. 10.1016/j.tibs.2011.11.005 - DOI - PMC - PubMed
    1. Biswas A., Das K. P. (2004). Role of ATP on the Interaction of Alpha-Crystallin with its Substrates and its Implications for the Molecular Chaperone Function. J. Biol. Chem. 279, 27942648–27942657. 10.1074/jbc.M404444200 - DOI - PubMed
    1. Bredemeier M., Lopes L. M., Eisenreich M. A., Hickmann S., Bongiorno G. K., d'Avila R., et al. (2018). Xanthine Oxidase Inhibitors for Prevention of Cardiovascular Events: a Systematic Review and Meta-Analysis of Randomized Controlled Trials. BMC Cardiovasc. Disord. 18, 1824. 10.1186/s12872-018-0757-9 - DOI - PMC - PubMed